Shattuck Labs, Inc. (NASDAQ: STTK) is a Healthcare company (Biotechnology) with a market capitalization of $467M. The Maz Rating grades it against the other companies in its sector.
Shattuck Labs, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $4.59, Shattuck Labs, Inc. trades at 4.3x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -46.5%, return on invested capital of -36.8% and a free cash flow yield of -10.6%. On the balance sheet: a debt-to-equity ratio of 0.01 and a current ratio of 15.80. Over the past 52 weeks the share price ranged from $1.88 to $8.33, with a beta of 1.13.
Shattuck Labs, Inc. does not currently pay a dividend.
9 Wall Street analyst ratings cover the stock: 9 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.